Inspire 4063, 4323 User Manual
SYSTEM IMPLANT MANUAL
Inspire II Implantable Pulse Generator Model 3024
Stimulation Lead Model 4063
Sensing Lead Model 4323
Rx Only
Table of Contents
Explanation of Symbols on Product or Package Labeling 5
Indications for Use 7
Therapy Overview 7
Overview of the Manual 8
Sterile Package Contents 8
Implanted Component Descriptions 9
IPG 9
Leads 10
Contraindications 11
Adverse Effects 11
Warnings and Precautions 12
Warnings 12
Precautions 13
Storage and Handling 15
IPG 15
Leads 16
Physician Training 17
System Implant 17
Implantable Components 17
Procedure Overview 18
Patient Preparation 18
Surgical Materials 18
Precautions for Handling Components 18
Stimulation Lead Implant 20
Test Stimulation 22
Securing the Stimulation Lead 23
Making the IPG Pocket 25
Tunneling the Lead 25
Respiratory Sensing Lead Implant 26
Connecting the Leads and IPG 29
Implanting the IPG 32
Completing the Implant Procedure 33
Postoperative Follow-up 33
Physician Instructions to Patient 34
Patient Registration 34
Therapy Activation 34
Therapy Titration 34
Inspire System Models 3024, 4063, 4323 English 3
Surgical Revision and Explant 35
Lead Repositioning 35
System or IPG Explant 35
Explant Disposition 35
Clinical Summary 36
Stimulation Therapy for Apnea Reduction (STAR) Clinical Trial 36
Patients Studied 36
Study Design and Methods 37
Study Results 38
IPG Specifications 42
Factory Settings 42
Configurable Settings 43
Battery Information 44
Physical Description 45
Inspire Medical Systems Limited Warranty 46
4 English Inspire System Models 3024, 4063, 4323
Explanation of Symbols on Product or Package Labeling
Refer to the appropriate product for symbols that apply.
Open here
Do not reuse
Sterilized using ethylene-oxide gas
Use by
Serial number
Temperature limitation
Lead that inserts into SENSE (sensing) port of IPG
Lead that inserts into STIM (stimulation) port of IPG
Caution, consult accompanying documents
Consult instructions for use
Date of manufacture
Manufacturer
Reference number
The Inspire therapy system is MR unsafe
Inspire System Models 3024, 4063, 4323 English 5
The following is a trademark of Inspire Medical Systems, Inc.: Inspire
®
6 English Inspire System Models 3024, 4063, 4323
Indications for Use
Stimulation lead
Respiratory
sensing lead
Implantable pulse
generator
Inspire Upper Airway
evere obstructive sleep apnea (OSA) (apnea-hypopnea index [AHI] of greater than or equal to
s
15 and less than or equal to 65). Inspire UAS is used in adult patients 22 years of age and older
who have been confirmed to fail or cannot tolerate positive airway pressure (PAP) treatments
(such as continuous positive airway pressure [CPAP] or bi-level pos
[BPAP] machines) and who do not have a complete concentric collapse at the soft palate level.
PAP failure is defined as an inability to eliminate OSA (AHI of greater than 15 despite PAP
usage), and PAP intoleranc
(1) Inability to use PAP (greater than 5 nights per week of usage; usage defined as greater
than 4 hours of use per night), or
(2) Unwillingness to use PAP (for example, a patient returns the PAP system after
attempting to use it).
Stimulation (UAS) is used to treat a subset of patients with moderate to
itive airway pressure
e is defined as:
Therapy Overview
The implanted components of the Inspire therapy system consist of the Inspire II implantable
pulse generator (IPG) Model 3024, the stimulation lead model 4063, and the respiratory
sensing lead model 4323 (Figure 1).
Figure 1. Inspire system implanted components
When therapy is on, the Inspire system detects the patient’s respiratory effort and maintains
airway patency with mild stimulation of the hypoglossal nerve.
Therapy settings are stored in the IPG and configured by the physician using an external
programmer.
Inspire System Models 3024, 4063, 4323 English 7
The patient uses their Inspire sleep remote to turn therapy on before they go to sleep and to
turn therapy off when they wake up. The sleep remote also provides the ability to pause therapy
and adjust stimulation amplitude within physician defined limits.
Overview of the Manual
This manual provides physicians with implant procedure and follow-up care information for the
Inspire system. The manual includes instructions for handling, storing, and implanting the leads
and IPG. Critical therapy information is provided for you to discuss with your patient, as well as
instructions for follow-up care. General resterilization instructions for the IPG are also provided;
the leads cannot be resterilized. Information on explanting the IPG and leads is included. This
manual also explains how to register your patient's medical devices.
Sterile Package Contents
The leads and IPG are provided in separate sterile packages.
Inspire II Implantable Pulse Generator (Model 3024)
• One IPG
• One hex wrench
• Product literature (system implant manual, patient manual, patient registration form, and
patient ID card)
8 English Inspire System Models 3024, 4063, 4323
Implanted Component Descriptions
STIM port
SENSE port
Top view
Side view
Set screw locations
The implanted components of the Inspire system consist of an IPG, a respiratory sensing lead,
and a stimulation lead. All implanted Inspire system components are intended for single-use
only.
IPG
The IPG (Figure 2) contains the battery and electronics that deliver Inspire therapy and store
the therapy settings.
Figure 2. IPG
The IPG has two 3.2 mm low-profile connector ports (Figure 3), which are compatible with the
connectors on the stimulation lead and the respiratory sensing lead. After inserting the lead
connectors into the IPG connector ports, the lead connectors are secured using the set screws
next to the connector ports.
Figure 3. IPG connector ports
Inspire System Models 3024, 4063, 4323 English 9
Leads
Shorting bar
Connector pin
Sealing rings
Lead body
Anchor: movable
Sensor tip
Anchor: fixed
Sensor membrane
Sealing rings
Self-sizing cuff
Connector
Anchor
Sigmoid lead body
Connector pin
The respiratory sensing lead (Figure 4) detects respiratory effort. The lead has a pressuresensitive membrane that converts the mechanical energy of respiration into an electrical signal.
Figure 4. Respiratory sensing lead
The stimulation lead (Figure 5) delivers stimulation to the hypoglossal nerve. The lead has a
flexible, self-sizing stimulation cuff. The stimulating electrodes are on the inner surface of the
cuff.
Figure 5. Stimulation lead
10 English Inspire System Models 3024, 4063, 4323
Contraindications
Contraindications for the use of Inspire UAS therapy include the following:
• Central + mixed apneas > 25% of the total apnea–hypopnea index (AHI)
• Any anatomical finding that would compromise the performance of upper airway
stimulation, such as the presence of complete concentric collapse of the soft palate
• Any condition or procedure that has compromised neurological control of the upper airway
• Patients who are unable or do not have the necessary assistance to operate the sleep
remote
• Patients who are pregnant or plan to become pregnant
• Patients who will require magnetic resonance imaging (MRI)
• Patients with an implantable device that may be susceptible to unintended interaction with
the Inspire system. Consult the device manufacturer to assess the possibility of interaction.
Adverse Effects
Possible adverse effects include, but are not limited to, the following patient related conditions:
• Damage to blood vessels in the vicinity of implant
• Excessive bleeding
• Nerve trauma or damage
• Allergic and/or rejection response to the implanted materials
• Infection
• Local irritation, seroma, hematoma, erosion, or swelling
• Persistent pain, numbness, or inflammation at the implant site
• Discomfort from the stimulation
• Tongue movement restrictions, irritation resulting from tongue abrasions on preexisting
sharp or broken teeth
• Tongue soreness or weakness
• Problems with swallowing or speaking
• Undesirable change in stimulation over time, possibly related to tissue changes around the
electrode(s), shifts in electrode position, loose electrical connections, or lead fractures
• Fibrosis to the extent that it makes it difficult to remove the system without damaging
surrounding structures
•Dry mouth
• Other acute symptoms (i.e., headaches, coughing, choking, dysphasia, and speech
related events)
• Insomnia
Inspire System Models 3024, 4063, 4323 English 11
Warnings and Precautions
Warnings
•Training — Physicians must be trained in the proper use and surgical procedure before
implantation or operation of the device.
• Pediatrics — The majority of cases of obstructive sleep apnea in younger pediatric
patients (e.g., less than 18 years of age) result from anatomical obstruction (e.g.,
adenotonsillar hypertrophy) that would not be appropriately managed with
neurostimulation therapy.
• Components — The use of components not provided by Inspire Medical Systems may
result in damaged components, improper operation, or increased risks to the patient.
• Diathermy — Do not use shortwave diathermy, microwave diathermy or therapeutic
ultrasound diathermy (all now referred to as diathermy) on patients implanted with a
neurostimulation system. Energy from diathermy can be transferred through the implanted
system and can cause tissue damage at the location of the implanted electrodes, resulting
in severe injury or death.
Diathermy can also damage the neurostimulation system components, resulting in loss of
therapy and requiring additional surgery for system explantation and replacement. Advise
your patient to inform all their health care professionals that they should not be exposed
to diathermy treatment.
Injury to the patient or damage to the device can occur during diathermy treatment when:
• The neurostimulation system is turned on or off
• Diathermy is used anywhere on the body—not just at the location of the
neurostimulation system
• Diathermy delivers heat or no heat
• Any component of the neurostimulation system (lead, extension, neurostimulator)
remains in the body
• Magnetic Resonance Imaging — The use of magnetic resonance imaging (MRI) among
IPG patients has been contraindicated by MRI manufacturers. Patients who have any
component of the Inspire system implanted should not undergo MRI. MRI can cause
tissue damage as well as damage to the Inspire system and components.
• Sleep remote use — When operating their Inspire sleep remote, patients should use
special care near flammable or explosive atmospheres. An interaction between the
flammable or explosive atmospheres and the battery in the sleep remote could occur. The
consequences of using the battery-powered sleep remote near flammable or explosive
atmospheres are unknown.
• Body Mass Index (BMI) — BMI greater than 32 was not studied as part of the pivotal trial.
Based on data from the feasibility study, it may be associated with decreased likelihood of
response to treatment. Use of Inspire UAS in higher BMI patients is not recommended due
to unknown effectiveness and safety.
12 English Inspire System Models 3024, 4063, 4323
Precautions
General
• Pediatrics — The safety of implantation and the parameters for safe and effective
stimulation of the hypoglossal nerve have not been evaluated in clinical studies for patients
less than 22 years of age. There may be increased risk of nerve injury and stimulationrelated adverse events in this population, particularly in younger children (e.g., less than
12 years of age).
• Expiration date — Do not use any Inspire system product after its expiration date.
• Component handling — Precautions related to component handling during the implant
procedure are located on page 18.
• Storage temperature ranges
– Do not expose the IPG to temperatures above 52°C (125°F) or below -18°C (0°F).
– Do not expose the leads to temperatures above 55°C (131°F) or below -10°C (14°F).
Electromagnetic compatibility and medical procedures
For information on MRI and diathermy, see “Warnings” on page 12.
The IPG is designed to ensure immunity from most common sources of electromagnetic
disturbance. In most cases, turning off the electromagnetic disturbance source, or moving away
from the electromagnetic disturbance source will return the IPG to normal operation. Extremely
strong sources of electromagnetic disturbance could interfere with normal IPG operation,
causing the IPG to reset and requiring the IPG to be reconfigured. To reduce the possibility of
electromagnetic interference (EMI), patients are recommended to use therapy only while
asleep.
Medical environment
Electrocautery, irradiation, lithotripsy, RF-ablation, X-ray, and fluoroscopy are typical
electromagnetic disturbance sources in hospital and clinical environments. Medical treatments
that use ultrasonics, defibrillation, or radiation can adversely affect the Inspire system.
• Electrocautery — Electrocautery may induce failure of the IPG. Alternatives to
electrocautery should be used when available. Bipolar electrocautery should be used if
alternatives are not available. If electrocautery must be used in the vicinity of the IPG,
therapy should be turned off.
• Radiation therapy — The IPG should not be directly irradiated by therapeutic levels of
ionizing radiation (such as produced by cobalt machines or linear accelerators used for
cancer treatment) because of the risk of permanent damage to the IPG circuitry. If such
therapy is required in the vicinity of the IPG, shield the device and confirm its function after
treatment.
• RF-ablation — RF-ablation should not be used directly over the implant sites.
• X-ray and fluoroscopy — Exposure to diagnostic X-ray or fluoroscopic radiation should
not affect the IPG or leads.
• Therapeutic ultrasound — Exposure to high ultrasonic frequencies may result in damage
to the IPG or leads. It is not recommended to use high-output ultrasonic devices, such as
an electrohydraulic lithotriptor or bone growth stimulator on patients with an implanted IPG.
Inspire System Models 3024, 4063, 4323 English 13
• Ultrasonic scanning — While there is no danger to the patient, ultrasonic scanning
equipment could cause mechanical damage to an IPG or leads if used directly over the
implant sites.
• Defibrillation — Defibrillation used anywhere on the patient’s body can cause permanent
damage to the IPG. Following defibrillation, the IPG should be interrogated to verify normal
operation.
Home or work environment
Based on laboratory tests of the IPG, the device should not be affected by the normal operation
of electrical equipment, household appliances, electric machine shop tools, microwave ovens,
internal combustion engines, low-powered radio, and microwave frequency transmitters. All
such equipment should be kept in good repair and properly grounded to avoid the possibility of
electrical shock or interference with the proper operation of the IPG.
Inspire therapy is intended for use during sleep only and should be turned off otherwise.
• Equipment operation — Patients should not operate potentially dangerous equipment,
such as power tools, during stimulation.
• Theft detectors — In general, theft detectors have been known to cause inadvertent and
potentially uncomfortable stimulation in neurological stimulation systems. Patients should
use care to avoid theft detectors and be aware in the presence of such systems.
• High-powered electric fields — Consult Inspire Medical Systems when the patient will
be in an area where contact with current carrying conductors is possible or near
high-powered electromagnetic fields radiated by arc welding units, induction furnaces,
induction stoves, resistance welders, radio or microwave frequency transmitters, etc.
• Mobile and cellular phones — Maintain a separation of at least 15 cm (6 in) between a
phone and the IPG.
14 English Inspire System Models 3024, 4063, 4323
Storage and Handling
Recommendations for storage and handling of the IPG and leads are provided in this section.
Inspire Medical Systems sterilizes the IPG and leads with ethylene oxide (EtO) prior to
shipment.
Information about precautions for handling components is located on page 18.
IPG
Inspect the IPG and the lead sterile packages prior to opening. If the IPG package is damaged,
the IPG may be damaged as well. Return a damaged package to Inspire Medical Systems; see
the back cover of this manual for addresses.
Table 1. IPG Storage and Handling
Handling and Storage: Acceptable Unacceptable
Store and transport IPG within the
following environmental temperature
limits: -18°C (0°F) to +52°C (125°F).
A full or partial electrical reset condition
may occur at temperatures below
-18°C (0°F).
Resterilization
Resterilization is not allowed.
• IPGs cannot be resterilized. If the
sterile package seal is broken, or if
the packages are otherwise
damaged, do not use.
• Return the package to your local
Inspire Medical Systems
representative, see back cover for
address.
Do not implant the IPG if it has been dropped on
a hard surface from a height of 30 cm
(12 in) or greater.
Inspire System Models 3024, 4063, 4323 English 15
Loading...